Results 41 to 50 of about 2,190,813 (317)
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Shanghai yufang yixue, 2022 ObjectiveTo analyze the effect of frailty status on the risk of mortality in a community-based population aged 45 years and above in Shanghai with different characteristics， and to provide further basis for population-based interventions for frailty and ...
SUN Shuangyuan +7 more
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
The mortality risk in patients with early onset colorectal cancer: the role of comorbidities
Frontiers in Oncology, 2023 The global incidence of early-onset colorectal cancer (EO-CRC) is increasing. Although the mortality rate is relatively stable, some comorbidities have been associated with a higher mortality rate. This study estimated the mortality risk in patients with
Shou-Chun Yu +9 more
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono +7 more
wiley +1 more source
Mortality Risk in IgA Nephropathy [PDF]
Journal of the American Society of Nephrology, 2019 IgA nephropathy (IgAN) is a common form of primary GN known to affect about 200,000–350,000 persons per year globally,[1][1] most frequently in Asia and least frequently in Africa.[2][2] Presently, the diagnosis of IgAN is established only by kidney biopsy and immunofluorescence microscopy;
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
Natural Disasters and Mortality: A Probabilistic Analysis for Argentina (1970-2015)
Revista de Estudios Andaluces, 2020 The frequency and intensity of natural disasters are expected to increase due to climate change. In this context, this work advances in the estimation of an absolute measure of mortality risk generated by natural disasters, in regions of Argentina.
Fernando Antonio Ignacio González
doaj +1 more source
Parity and men's mortality risks [PDF]
The European Journal of Public Health, 2011 Most studies on associations between parity and mortality focus on women, and find a negative correlation or U-shaped pattern. If and why having children is associated with mortality among men is less clear. Our objective was to improve understanding of the association between men's parity and mortality, and to investigate mechanisms potentially ...
Keizer, Renske +2 more
openaire +2 more sources
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source